Upcoming Events

By Dr. Robert Katz, LSI Board Chair and LSI Medical Advisory Board Chair (CAR T-cell therapy, typically used in cancer treatment, is a form of immunotherapy.In CAR T-cell therapy, blood […]

By Dr. Robert Katz Medical Advisory Board The effects of exercise intervention on health-related quality of life in patients with systemic lupus in the journal Healthcare. In this study, 1,058 [...]

By Dr. Robert Katz Medical Advisory Board Pharmacies are now offering booster shots for immunocompromised patients. Many lupus patients qualify because they are being treated with prednisone and [...]

By Dr. Robert Katz According to the CDC, the Delta variant of COVID-19 is more contagious – more than 2x as contagious as previous variants; some data suggest the Delta […]

What is SAPHNELO and how does it work?SAPHNELO is a first-in-class type I interferon (IFN) receptor antagonist, a human monoclonal antibody that binds to subunit 1 of the type I […]

By Dr. Robert Katz Europe has now approved the use of Benlysta to treat children with lupus. Benlysta has the generic name belimumab. The “mab” at the end indicates it […]

By Dr. Robert Katz In a paper written by Rasmus, Westermann, and others, the authors ask the question as to whether cancer risk is increased in patients with skin lupus […]

By Dr. Robert Katz A research paper in the journal Lupus entitled, “The Importance of Pregnancy Planning in Lupus Pregnancies,” Rajendran, Euty, and other authors from Duke University Medical [...]

By Dr. Robert Katz An article in the journal Lupus discusses delayed diagnosis. The conclusion of the authors is that a longer time to diagnosis was associated with worse outcomes. […]